A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension

Clinical trial NCT02338843 · COMPLETED

Trial details

NCT number: NCT02338843
Sponsor: La Jolla Pharmaceutical Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Catecholamine-resistant Hypotension (CRH)Distributive Shock High Output Shock Sepsis

Start date: 2015-03-01
Primary completion: 2016-12-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.